Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Yuko, Tanibuchi"'
Publikováno v:
Neuropsychopharmacology Reports, Vol 44, Iss 1, Pp 176-186 (2024)
Abstract Objective To examine the clinical characteristics of over‐the‐counter (OTC) drug abusers in psychiatric practice in Japan. Method We examined the attributes, ICD‐10 subcategory, and comorbid mental disorders of patients who mainly abus
Externí odkaz:
https://doaj.org/article/b7c011e39201413d81633d80d3d7ca96
Autor:
Hiroko Kotajima‐Murakami, Ayumi Takano, Shinya Hirakawa, Yasukazu Ogai, Daisuke Funada, Yuko Tanibuchi, Eriko Ban, Minako Kikuchi, Hisateru Tachimori, Kazushi Maruo, Takahiro Kawashima, Yui Tomo, Tsuyoshi Sasaki, Hideki Oi, Toshihiko Matsumoto, Kazutaka Ikeda
Publikováno v:
Neuropsychopharmacology Reports, Vol 42, Iss 1, Pp 92-104 (2022)
Abstract Aim No effective pharmacological interventions have been developed for patients with methamphetamine use disorder. Ifenprodil is a blocker of G protein‐activated inwardly rectifying potassium channels, which play a key role in the mechanis
Externí odkaz:
https://doaj.org/article/1a041988e188411f832f972ce2fb619a
Autor:
Toshihiko Matsumoto, Toshitaka Kawabata, Kyoji Okita, Yuko Tanibuchi, Daisuke Funada, Maki Murakami, Takashi Usami, Rie Yokoyama, Nobuya Naruse, Yuzo Aikawa, Aizo Furukawa, Chie Komatsuzaki, Nozomu Hashimoto, Osamu Fujita, Aiko Umemoto, Ariyuki Kagaya, Takuya Shimane
Publikováno v:
Neuropsychopharmacology Reports, Vol 40, Iss 4, Pp 332-341 (2020)
Abstract Aim The objective of the current study was to identify risk factors that affect the onset of dependence and chronic psychosis due to cannabis use. Methods We examined clinical genetic factors, psychiatric disorders prior to cannabis use, sta
Externí odkaz:
https://doaj.org/article/fc89df19d6584579b55439fcfddf56ca
Autor:
Hiroko Kotajima‐Murakami, Ayumi Takano, Yasukazu Ogai, Shotaro Tsukamoto, Maki Murakami, Daisuke Funada, Yuko Tanibuchi, Hisateru Tachimori, Kazushi Maruo, Tsuyoshi Sasaki, Toshihiko Matsumoto, Kazutaka Ikeda
Publikováno v:
Neuropsychopharmacology Reports, Vol 39, Iss 2, Pp 90-99 (2019)
Abstract Aims Pharmacotherapy for methamphetamine dependence has not yet been developed in Japan or elsewhere in the world. Ifenprodil is a blocker of G protein‐activated inwardly rectifying potassium channels that play a key role in the mechanism
Externí odkaz:
https://doaj.org/article/4c02b4ea4a5943d186af0032b2ce2776
Autor:
Daisuke Funada, Toshihiko Matsumoto, Yuko Tanibuchi, Yasunari Kawasoe, Satoru Sakakibara, Nobuya Naruse, Shunichiro Ikeda, Takashi Sunami, Takeo Muto, Tetsuji Cho
Publikováno v:
Neuropsychopharmacology Reports, Vol 39, Iss 2, Pp 119-129 (2019)
Abstract Aims The use of new psychoactive substances (NPS) has become increasingly widespread over the last decade, in Japan and internationally. NPS are associated with a range of increasingly serious clinical, public, and social issues. Political m
Externí odkaz:
https://doaj.org/article/faad6dca49594a6984bd5755f44daf33
Publikováno v:
Neuropsychopharmacology Reports, Vol 38, Iss 4, Pp 189-196 (2018)
Abstract Aims This study aimed to investigate the influence of tightened regulations on new psychoactive substances in patients with disorders related to these drugs in Japan. Methods We used a biennial nationwide survey on drug‐related psychiatric
Externí odkaz:
https://doaj.org/article/a41b1ad6fdc7492e88ff3a63c7060567
Autor:
Daisuke Funada, Toshihiko Matsumoto, Chie Komatsuzaki, Kyoji Okita, Takashi Usami, Yuzo Aikawa, Aizo Furukawa, Takuya Shimane, Osamu Fujita, Toshitaka Kawabata, Ariyuki Kagaya, Maki Murakami, Yuko Tanibuchi, Aiko Umemoto, Nozomu Hashimoto, Nobuya Naruse, Rie Yokoyama
Publikováno v:
Neuropsychopharmacology Reports
Aim The objective of the current study was to identify risk factors that affect the onset of dependence and chronic psychosis due to cannabis use. Methods We examined clinical genetic factors, psychiatric disorders prior to cannabis use, starting age
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f64e51df3cc275487c674526853e09a9
https://doi.org/10.1002/npr2.12133
https://doi.org/10.1002/npr2.12133
Autor:
Hiroko Kotajima‐Murakami, Ayumi Takano, Shinya Hirakawa, Yasukazu Ogai, Daisuke Funada, Yuko Tanibuchi, Eriko Ban, Minako Kikuchi, Hisateru Tachimori, Kazushi Maruo, Takahiro Kawashima, Yui Tomo, Tsuyoshi Sasaki, Hideki Oi, Toshihiko Matsumoto, Kazutaka Ikeda
Publikováno v:
Neuropsychopharmacology reports. 42(1)
No effective pharmacological interventions have been developed for patients with methamphetamine use disorder. Ifenprodil is a blocker of G protein-activated inwardly rectifying potassium channels, which play a key role in the mechanism of action of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5da38dc9a93f517924357d832f04de08
https://pubmed.ncbi.nlm.nih.gov/35068087
https://pubmed.ncbi.nlm.nih.gov/35068087
Publikováno v:
Neuropsychopharmacology Reports
Aims This study aimed to investigate the influence of tightened regulations on new psychoactive substances in patients with disorders related to these drugs in Japan. Methods We used a biennial nationwide survey on drug‐related psychiatric disorder
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97d4f0b763f9c24302feadbf5a1b2585
https://doi.org/10.1002/npr2.12035
https://doi.org/10.1002/npr2.12035
Autor:
Maki Murakami, Daisuke Funada, Kazushi Maruo, Hisateru Tachimori, Yuko Tanibuchi, Shotaro Tsukamoto, Yasukazu Ogai, Hiroko Kotajima-Murakami, Kazutaka Ikeda, Ayumi Takano, Toshihiko Matsumoto, Tsuyoshi Sasaki
Publikováno v:
Neuropsychopharmacology Reports
Aims Pharmacotherapy for methamphetamine dependence has not yet been developed in Japan or elsewhere in the world. Ifenprodil is a blocker of G protein‐activated inwardly rectifying potassium channels that play a key role in the mechanism of action
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::266d79f9ad5ab2d47c00e42ed853ecc5
https://pubmed.ncbi.nlm.nih.gov/30756527
https://pubmed.ncbi.nlm.nih.gov/30756527